More serious risks include hypoglycemia (particularly when used with insulin or sulfonylureas), acute kidney injury, pancreatitis, gallbladder disease, and potential thyroid C-cell tumors (based on animal studies)
Healthier ingredients, lower prices, or more eco friendly packaging can help
Prospective studies will be needed to determine whether semaglutide truly increases the risk of NAION, and whether certain formulations, doses, or patient groups are particularly vulnerable
At Ivm Health, our approach goes beyond prescribing
Our medically-managed GLP-1 peptide weight loss focuses on your complete wellness, not just selling injections
We also monitor you clinically with scheduled follow-ups and labs